100 related articles for article (PubMed ID: 2645670)
1. Postoperative prognostic indicators of control of acromegaly.
Yamada S; Aiba T; Shishiba Y
Surg Neurol; 1989 Jan; 31(1):14-9. PubMed ID: 2645670
[TBL] [Abstract][Full Text] [Related]
2. Preoperative growth hormone response to thyrotropin-releasing hormone and oral glucose tolerance test in acromegaly: a retrospective evaluation of 50 patients.
De Marinis L; Mancini A; Bianchi A; Gentilella R; Valle D; Giampietro A; Zuppi P; Anile C; Maira G; Giustina A
Metabolism; 2002 May; 51(5):616-21. PubMed ID: 11979395
[TBL] [Abstract][Full Text] [Related]
3. Clinical use of pre- and postsurgical evaluation of abnormal GH responses in acromegaly.
Arosio M; Giovanelli MA; Riva E; Nava C; Ambrosi B; Faglia G
J Neurosurg; 1983 Sep; 59(3):402-8. PubMed ID: 6411870
[TBL] [Abstract][Full Text] [Related]
4. Long-term growth hormone responses to nonspecific hypothalamic hormones in acromegalic patients.
Watanabe M; Kuwayama A; Nakane T; Kanie N; Kato T; Takahashi T; Kageyama N
Surg Neurol; 1985 Oct; 24(4):449-56. PubMed ID: 4035555
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of selective transsphenoidal adenomectomy by endocrinological testing and somatomedin-C measurement in acromegaly.
Losa M; Oeckler R; Schopohl J; Müller OA; Alba-Lopez J; von Werder K
J Neurosurg; 1989 Apr; 70(4):561-7. PubMed ID: 2647918
[TBL] [Abstract][Full Text] [Related]
6. Value of growth hormone dynamics and somatomedin C (insulin-like growth factor I) levels in predicting the long-term benefit after transsphenoidal surgery for acromegaly.
Arafah BM; Rosenzweig JL; Fenstermaker R; Salazar R; McBride CE; Selman W
J Lab Clin Med; 1987 Mar; 109(3):346-54. PubMed ID: 3102658
[TBL] [Abstract][Full Text] [Related]
7. Postoperative persistent thyrotrophin releasing hormone-induced growth hormone release predicts recurrence in patients with acromegaly.
Biermasz NR; Smit JW; van Dulken H; Roelfsema F
Clin Endocrinol (Oxf); 2002 Mar; 56(3):313-9. PubMed ID: 11940042
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone releasing factor-test in acromegaly: comparison with other dynamic tests.
Losa M; Schopohl J; Stalla GK; Müller OA; von Werder K
Clin Endocrinol (Oxf); 1985 Aug; 23(2):99-109. PubMed ID: 3931944
[TBL] [Abstract][Full Text] [Related]
9. The natural course of growth hormone-secreting pituitary adenomas after surgery alone--clinical significance of the growth hormone response to thyrotropin-releasing hormone and luteinizing hormone-releasing hormone.
Mukada K
Neurol Med Chir (Tokyo); 1990 Apr; 30(4):251-7. PubMed ID: 1696695
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone (GH) and prolactin responses to repetitive administration of GH-releasing hormone in acromegaly.
Losa M; Schopohl J; König A; Müller OA; von Werder K
J Clin Endocrinol Metab; 1986 Aug; 63(2):475-80. PubMed ID: 3088026
[TBL] [Abstract][Full Text] [Related]
11. [Reevaluation of the I-dopa test in acromegaly: anatomo-clinical and prognostic correlations].
De Marinis L; Mancini A; Zuppi P; Fiumara C; Iacona T; Conte G; Fabrizi ML; Valle D; Anile C; Maira G
Minerva Chir; 1993 Nov; 48(21-22):1337-40. PubMed ID: 8152567
[TBL] [Abstract][Full Text] [Related]
12. Predicting long-term remission by measuring immediate postoperative growth hormone levels and oral glucose tolerance test in acromegaly.
Kim EH; Oh MC; Lee EJ; Kim SH
Neurosurgery; 2012 May; 70(5):1106-13; discussion 1113. PubMed ID: 22067418
[TBL] [Abstract][Full Text] [Related]
13. The GH-releasing hormone (GHRH) test in acromegaly before and after adenomectomy.
Giusti M; Lomeo A; Monachesi M; Mazzocchi G; Attanasio R; Sessarego P; Mignone D; Del Monte P; Giordano G
J Endocrinol Invest; 1987 Apr; 10(2):143-51. PubMed ID: 3108356
[TBL] [Abstract][Full Text] [Related]
14. Acromegaly with normal growth-hormone levels and pituitary histology. Case report.
Feingold KR; Goldfine ID; Weinstein PR
J Neurosurg; 1979 Apr; 50(4):503-7. PubMed ID: 106097
[TBL] [Abstract][Full Text] [Related]
15. Value of early postoperative random growth hormone levels and nadir growth hormone levels after oral glucose tolerance testing in acromegaly.
Rotermund R; Burkhardt T; Rohani Z; Jung R; Aberle J; Flitsch J
Growth Horm IGF Res; 2018 Aug; 41():64-70. PubMed ID: 29555234
[TBL] [Abstract][Full Text] [Related]
16. Prolactin secretion in acromegalic patients before and after selective adenomectomy.
Tsuchiya H; Onishi T; Takamoto S; Imanaka S; Saitoh Y; Mogami H; Mori S; Uozumi T; Kumahara Y
J Clin Endocrinol Metab; 1985 Jul; 61(1):104-9. PubMed ID: 3923026
[TBL] [Abstract][Full Text] [Related]
17. Serum growth hormone and prolactin response to thyrotropin-releasing hormone in patients with acromegaly before and after surgery.
Samaan NA; Leavens ME; Jesse RH
J Clin Endocrinol Metab; 1974 Jun; 38(6):957-63. PubMed ID: 4208807
[No Abstract] [Full Text] [Related]
18. Insulin-like growth factor binding protein-3 levels during early and late follow-up after surgery in acromegalic patients.
Charalampaki P; Hildebrandt G; Schaeffer HJ; Schönau E; Klug N
Exp Clin Endocrinol Diabetes; 1998; 106(2):130-4. PubMed ID: 9628244
[TBL] [Abstract][Full Text] [Related]
19. TRH/GnRH test in acromegaly. Long-term follow-up experience with successfully treated patients.
Brockmeier SJ; Buchfelder M; Fahlbusch R
Horm Metab Res; 1993 May; 25(5):275-7. PubMed ID: 8330864
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone responses to oral glucose loading measured by highly sensitive enzyme immunoassay in normal subjects and patients with glucose intolerance and acromegaly.
Hattori N; Shimatsu A; Kato Y; Koshiyama H; Ishikawa Y; Assadian H; Tanoh T; Nagao M; Imura H
J Clin Endocrinol Metab; 1990 Mar; 70(3):771-6. PubMed ID: 2106529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
